| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-918 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-44 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-16 |
| filingDate |
1991-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2fefa43976258a983a70083a3f51397 |
| publicationDate |
1992-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0476849-A2 |
| titleOfInvention |
Human cytosolic phospholipase A2 |
| abstract |
This invention includes a process of purifying a novel, intracellular phospholipase A₂ with an approximate molecular weight of 100,000 daltons. The invention also contains the novel PLA₂ enzyme and provides a partial amino acid sequence. The claimed PLa₂ is a useful tool for developing medicinally important anti-inflammatory and anti-ischemic drugs. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012078797-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103338636-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004003193-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7015006-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5453443-A |
| priorityDate |
1990-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |